HP
ATRA icon

Harbourvest Partners’s Atara Biotherapeutics ATRA Stock Holding History

Harbourvest Partners’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-422
Closed -$411K – 22
2018
Q1 		$411K Hold
422
– – 0.44% 16
2017
Q4 		$191K Hold
422
– – 0.15% 21
2017
Q3 		$174K Hold
422
– – 0.11% 20
2017
Q2 		$148K Hold
422
– – 0.06% 22
2017
Q1 		$217K Hold
422
– – 0.12% 18
2016
Q4 		$150K Hold
422
– – 0.09% 14
2016
Q3 		$226K Hold
422
– – 0.12% 9
2016
Q2 		$237K Hold
422
– – 0.11% 19
2016
Q1 		$201K Hold
422
– – 0.09% 20
2015
Q4 		$278K Hold
422
– – 0.1% 19
2015
Q3 		$331K Buy
+422
New +$515K 0.15% 17

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return